JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 140, Issue 3, 356-366, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


THE INTESTINAL INHIBITORY RESPONSE TO OXYTOCIN, VASOPRESSIN AND BRADYKININ

Bernard Levy 1

1 Department of General Pharmacology, Biological Research Division, Schering Corporation, Bloomfield, New Jersey

Evidence has been presented which indicates that each of the three polypeptides, oxytocin, vasopressin and bradykinin, produces a prompt inhibition of intestinal motility in the anesthetized dog. In the case of oxytocin and vasopressin, this smooth muscle inhibitory response is also reflected in the isolated guinea-pig ileum, the isolated guinea-pig tracheal chain and the rabbit ileum. Bradykinin produces a stimulant effect on these isolated smooth muscle preparations. In the anesthetized dog, the intestinal inhibitory responses to the three polypeptides are not reduced by adrenergic blockade, in the form of Dibenamine and dichloroisoproterenol; ganglionic blockade, in the form of chlorisondamine; or adrenergic neurone blockade, in the form of guanethidine or bretylium. Diphenhydramine and atropine both reduce the intestinal inhibitory responses to the three polypeptides without reducing the intestinal inhibitory responses to epinephrine or papaverine. The blocking action of diphenhydramine or atropine is probably not mediated through their antihistaminic or anticholinergic actions, respectively. However, this blocking effect is shared by other antihistamine drugs, such as tripelennamine and chlorpheniramine, and other anticholinergics, such as propantheline.

Accepted on March 25, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.